about
Therapy Insight: parenteral estrogen treatment for prostate cancer--a new dawn for an old therapyThe thyroid hormone receptor-associated protein TRAP220 is required at distinct embryonic stages in placental, cardiac, and hepatic developmentEarly hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer.Establishment and characterisation of two cell lines derived from a primary adenocarcinoma of the duodenum.Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladderExpression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication.Adhesion molecules and the normal endometrium.Androgen-dependent regulation of human MUC1 mucin expressionp27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo.Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalkDifferentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations.Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey.Transdermal estradiol therapy for advanced prostate cancer--forward to the past?CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium.The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines.Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.Transcriptional control of TFF3 (intestinal trefoil factor) via promoter binding sites for the nuclear factor kappaB and C/EBPbeta.TFF1 is membrane-associated in breast carcinoma cell line MCF-7.Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cellsExpression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.The effect of circulating antigen on the biodistribution of the engineered human antibody hCTM01 in a nude mice model.pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel.TGF-alpha can act as morphogen and/or mitogen in a colon-cancer cell line.Selective immortalization of a phenotypically distinct epithelial cell type by microinjection of SV40 DNA into cultured human milk cells.Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer--a pilot study.Transforming growth factor-beta distribution in basal cell carcinomas: relationship to proliferation index.The endometrium and embryo implantation. A receptive endometrium depends on more than hormonal influences.99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.Transdermal estradiol improves bone density when used as single agent therapy for prostate cancer.The expression pattern of MUC1 glycoforms and other biomarkers of endometrial receptivity in fertile and infertile women.Changes in vascular flow after transdermal oestradiol therapy for prostate cancer: a mechanism for cardiovascular toxicity and benefit?Human Cytomegalovirus: a neglected public health area of significant relevance to women, the foetus and new born. Time for action!Analysis of epitopes on endometrial epithelium by scanning immunoelectron microscopy.MUC 1: a genetic susceptibility to infertility?The resistant hepatocyte model of carcinogenesis in the rat: the apparent independent development of oval cell proliferation and early nodules.Expression of a truncated Brca1 protein delays lactational mammary development in transgenic miceExpression of the gene coding for a human mucin in mouse mammary tumor cells can affect their tumorigenicityThe product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tailPeroxidase-labelled lectin binding of human extravillous trophoblast
P50
Q28266853-D959195D-6394-4479-B333-431F80B47676Q28588734-64611C2F-681E-4446-B1D7-36E4E7C4AA41Q31153083-1F702CB9-53C5-42A1-B157-E39085ECB7E2Q33839942-6B168D7E-8158-4ED4-86F1-BEC84EC98D46Q33919299-AA5FF229-6D01-411F-8FD5-E0D8D6C20A6CQ34092016-68BAC039-B36D-41DD-A0AC-D5654229D90BQ34740205-5AE6A280-9546-4304-BDDC-EA7134A57CF1Q34775040-0FA35EE2-63AE-47B9-B0A4-CAF0A03E1D3EQ35071046-37E3B614-0023-46E1-8750-8CC29D4CA200Q35092971-926AF59B-33CB-41A1-89C3-67B4F2D0EA1EQ35786929-727D4DA5-D4B1-4CCF-95F1-DE4C1F3DE8C3Q36172022-A5A3E2AD-B7B5-41C1-8A08-C4855F9B1359Q39220470-5DCF3D56-23B8-4E3E-8BC8-D5CA75B07924Q39837222-4541840B-91C4-4DF8-88E4-D66B9EFF58AFQ40295742-75684047-6EE9-4DC9-B54C-EAC8B9D74FA9Q40456737-A0D42DA4-7D6A-41F3-8B24-5226B638ACA1Q40516820-2DD1EB1F-26BB-4496-A261-AD455AD7244DQ40549212-1C15885B-54BC-480D-B5C2-4EE29D316196Q40549222-7D204ECA-FC69-421F-AA8F-73C7E2B7FD29Q40631293-C86C1CB3-31EA-45D8-8FBA-053610BFB70FQ41119626-ECFAA647-5A88-4EBA-85A0-B71CE226B351Q41131482-9F110228-D095-4807-9520-5E24AD3681DEQ41248230-7346947D-D305-457D-929B-67314B94B512Q41487513-B4515E6C-BB66-4C8B-8C98-108BB5DE4F12Q41730875-CCE8A8BF-F7E5-4D8E-947D-B044C807D4BDQ42072658-40EE7E2A-040E-4454-8AF7-C31822F68BB3Q42497907-AD7C8C05-48D6-41DF-BC96-358144D0212BQ42769477-64D56721-E4BE-4B57-B657-E93E9D3A937DQ43950735-2F410BD6-65E3-44A7-9C06-1F630F4BB6AFQ45147210-B7324302-2781-406A-A53F-EE63B823C212Q46560933-C3646B55-0604-4C04-AD4D-BD340C04C75FQ46936650-29CF211F-3F01-4F3C-B021-21521DC9E199Q50599258-1FC9A444-053E-41EC-9FDC-27E241925023Q52122761-FE7E6FB8-227D-4C43-A646-55282C657272Q52135573-D2460AE9-F0BB-4BE3-9FB6-07EF7C20A8AEQ53464791-F3E8AAE3-2771-4904-9244-13CD7EE52302Q57204279-E353C6DF-B579-4E74-9994-46DFC22F0811Q67697120-DBBE0D17-7650-48F6-9172-BE527E9793F3Q68144941-CA11AB46-00BC-4751-B147-275B3EF7FB99Q68157124-0A903C8C-8EFE-4305-BC0E-E680D9B8D062
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
El-Nasir Lalani
@ast
El-Nasir Lalani
@en
El-Nasir Lalani
@es
El-Nasir Lalani
@nl
type
label
El-Nasir Lalani
@ast
El-Nasir Lalani
@en
El-Nasir Lalani
@es
El-Nasir Lalani
@nl
prefLabel
El-Nasir Lalani
@ast
El-Nasir Lalani
@en
El-Nasir Lalani
@es
El-Nasir Lalani
@nl
P106
P1153
7006038297
P31
P496
0000-0001-9733-459X